ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

Grantees Seek $433.5 Million for construction

November 17, 1978

Physician Indicted for Mail Fraud After allegedly Falsifying Data Of Patients On ECOG, CALGB Trials

March 30, 1984

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988